Centro Médico Teknon
Medication treatment for Parkinson's disease in Spain typically costs from $1,800 to $3,200. The total expense depends on the drug regimen, city, and clinic tier. In the US, similar treatments cost around $6,500 on average. Patients can save approximately 62% by choosing Spanish private clinics. These quotes usually include neurologist consultations and initial dose titration protocols.
Bookimed Expert Insight: Choosing a clinic like Centro Médico Teknon provides access to JCI-accredited care used by elite athletes. While basic medication costs are standardized, the value lies in specialized multidisciplinary teams. Clinics with large patient volumes, such as Hospital HM Madrid, offer more precise diagnostic imaging. This ensures pharmacological protocols are optimized early, potentially reducing long-term medication adjustments and related costs.
Why choose Spain for medication treatment for Parkinson's disease?
Access advanced Medication treatment for Parkinson's disease solutions in trusted clinics .
| Turkey | Austria | Spain | |
| Medication treatment for Parkinson's disease | from $1,000 | from $2,000 | from $1,800 |
No hidden fees – just official clinic prices. Pay at the clinic for Medication treatment for Parkinson's disease upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Medication treatment for Parkinson's disease and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Medication treatment for Parkinson's disease journey.
Day 1
Day 2
Day 3-7
Week 2
Week 3
Week 4
Post-Treatment
Please note, the treatment process and results can vary for each individual.
Principal investigator of 100+ clinical trials in neuroscience – Dr. Arroyo González heads the Neurology Department at Quironsalud Madrid.
Dr. Romero Imbroda, a Fellow of the European Board of Neurology, leads the Neurology Unit at Quirónsalud Marbella with a focus on Parkinson's disease.
Head of the Department of Neurosurgery at HM Hospitales Clinic – specializes in advanced treatments for neurological conditions.
Dr. Rodrigo Rocamora Zuniga is a neurologist who specializes in epilepsy. He leads the epilepsy department at HM Delfos Hospital in Spain. He is also a professor at UPF University. Dr. Rocamora earned his PhD from Bonn University in 2001. He completed his neurology training at Pontificia Universidad Católica de Chile and received his medical degree in Mendoza, Argentina.
Dr. Rocamora is accredited by the European Reference Network. He is an active member of SEN, CSUR, and EPI-Care. He has published over 100 scientific articles on drug-resistant epilepsy, epilepsy surgery, and cognitive impairment. His work has helped develop new protocols that have improved care for epilepsy patients.